Unjha Formul.

{
  "main_header": {
    "sid": 782664,
    "name": "Unjha Formul.",
    "stock_name": "Unjha Formul.",
    "full_name": "Unjha Formulations Ltd",
    "name_url": "stocks-analysis/unjha-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "21.26",
    "chg": 1.25,
    "chgp": "6.25%",
    "dir": 1,
    "prev_price": "20.01",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531762,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE576D01015",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "610 ",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/unjha-formul-782664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Unjha Formulations Ltd Downgraded to Strong Sell Amid Technical and Financial Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/unjha-formulations-ltd-downgraded-to-strong-sell-amid-technical-and-financial-weakness-3980901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/UnjhaFormulatio_mojoScore_3980901.png",
        "date": "2026-05-08 08:05:33",
        "description": "Unjha Formulations Ltd has been downgraded from a Sell to a Strong Sell rating as of 7 May 2026, reflecting deteriorating technical indicators and underwhelming financial performance. The company’s micro-cap status, combined with a sharp decline in share price and weak debt servicing ability, has prompted a reassessment of its investment appeal across quality, valuation, financial trend, and technical parameters."
      },
      {
        "title": "Unjha Formulations Ltd Upgraded to Sell on Technical Improvement Despite Mixed Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/unjha-formulations-ltd-upgraded-to-sell-on-technical-improvement-despite-mixed-fundamentals-3969563",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/UnjhaFormulatio_mojoScore_3969563.png",
        "date": "2026-04-30 08:03:55",
        "description": "Unjha Formulations Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 April 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The micro-cap pharmaceutical company’s Mojo Score has improved to 31.0, reflecting a nuanced change in market sentiment and technical trends, even as financial performance remains flat and long-term fundamentals show weaknesses."
      },
      {
        "title": "Why is Unjha Formulations Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-unjha-formulations-ltd-fallingrising-3969264",
        "imagepath": "",
        "date": "2026-04-30 01:38:25",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Volatility and Trading Dynamics</strong></p>\n<p>Despite opening the day with a gap down of 6.47%, the stock managed to recover strongly, touching an intraday high of ₹22.00. The trading range was wide, spanning ₹2.5, reflecting significant price fluctuations throughout the session. The weighted average price indicated that a larger volume of shares was traded closer to the day’s low, suggesting some selling pressure earlier in the day. However, the stock’s ability to rebound and close with a substantial gain highlights a shift in market sentiment.</p>\n<p>Intraday volatility was measured at 6.02%, underscoring the heightened price swings experienced by Unjha Formulations today. Such volatility often attracts active traders and can be indicative of underlying changes in investor perce..."
      },
      {
        "title": "Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs186-amid-market-pressure-3935953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/UnjhaFormulatio_priceRelatedfactors_3935953.png",
        "date": "2026-04-07 12:05:09",
        "description": ""
      },
      {
        "title": "Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs1899-amid-market-downturn-3930348",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/UnjhaFormulatio_priceRelatedfactors_3930348.png",
        "date": "2026-04-02 10:43:07",
        "description": ""
      },
      {
        "title": "Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs19-amid-market-downturn-3908352",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/UnjhaFormulatio_priceRelatedfactors_3908352.png",
        "date": "2026-03-23 15:51:49",
        "description": "A sharp decline of 9.31% today dragged Unjha Formulations Ltd to a fresh 52-week low of Rs 19, marking a significant underperformance against both its sector and the broader market. This drop comes amid a broader market sell-off, yet the stock’s fall notably outpaces the sector’s 3.63% decline and the Sensex’s 2.46% fall, highlighting company-specific pressures."
      },
      {
        "title": "Unjha Formulations Ltd Falls to 52-Week Low of Rs.19.15 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs1915-amidst-continued-downtrend-3873409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/UnjhaFormulatio_priceRelatedfactors_3873409.png",
        "date": "2026-03-05 10:10:04",
        "description": "Unjha Formulations Ltd’s shares declined to a fresh 52-week low of Rs.19.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and broader market indices, reflecting persistent concerns over its financial metrics and market positioning."
      }
    ],
    "total": 139,
    "sid": "782664",
    "stock_news_url": "https://www.marketsmojo.com/news/unjha-formulations-782664"
  },
  "announcements": [
    {
      "caption": "Declaration With Respect To Non-Applicability Of Large Corporate Framework Pursuant To SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018",
      "datetime": "07-May-2026",
      "details": "Declaration with respect to non-applicability of large corporate vide SEBI circular Dated 26.11.2018",
      "source": "BSE"
    },
    {
      "caption": "Declaration With Respect To Non-Applicability Of Large Corporate Framework Pursuant To SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018",
      "datetime": "07-May-2026",
      "details": "Declaration with respect to non-applicability of large corporate vide SEBI circular Dated 26.11.2018",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Board Meeting - Date: 18.05.2026 (AUDITED FINANCIAL RESULTS AS ON 31/03/2026)",
      "datetime": "22-Apr-2026",
      "details": "Unjha Formulations Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 inter alia to consider and approve Regulation 29(1)(a) of SEBI(LODR)2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "18 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Unjha Formulations Ltd Downgraded to Strong Sell Amid Technical and Financial Weakness

2026-05-08 08:05:33

Unjha Formulations Ltd has been downgraded from a Sell to a Strong Sell rating as of 7 May 2026, reflecting deteriorating technical indicators and underwhelming financial performance. The company’s micro-cap status, combined with a sharp decline in share price and weak debt servicing ability, has prompted a reassessment of its investment appeal across quality, valuation, financial trend, and technical parameters.

Read full news article

Unjha Formulations Ltd Upgraded to Sell on Technical Improvement Despite Mixed Fundamentals

2026-04-30 08:03:55

Unjha Formulations Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 29 April 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The micro-cap pharmaceutical company’s Mojo Score has improved to 31.0, reflecting a nuanced change in market sentiment and technical trends, even as financial performance remains flat and long-term fundamentals show weaknesses.

Read full news article

Why is Unjha Formulations Ltd falling/rising?

2026-04-30 01:38:25

Intraday Volatility and Trading Dynamics

Despite opening the day with a gap down of 6.47%, the stock managed to recover strongly, touching an intraday high of ₹22.00. The trading range was wide, spanning ₹2.5, reflecting significant price fluctuations throughout the session. The weighted average price indicated that a larger volume of shares was traded closer to the day’s low, suggesting some selling pressure earlier in the day. However, the stock’s ability to rebound and close with a substantial gain highlights a shift in market sentiment.

Intraday volatility was measured at 6.02%, underscoring the heightened price swings experienced by Unjha Formulations today. Such volatility often attracts active traders and can be indicative of underlying changes in investor perce...

Read full news article

Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-07 12:05:09

Read full news article

Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-02 10:43:07

Read full news article

Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-23 15:51:49

A sharp decline of 9.31% today dragged Unjha Formulations Ltd to a fresh 52-week low of Rs 19, marking a significant underperformance against both its sector and the broader market. This drop comes amid a broader market sell-off, yet the stock’s fall notably outpaces the sector’s 3.63% decline and the Sensex’s 2.46% fall, highlighting company-specific pressures.

Read full news article

Unjha Formulations Ltd Falls to 52-Week Low of Rs.19.15 Amidst Continued Downtrend

2026-03-05 10:10:04

Unjha Formulations Ltd’s shares declined to a fresh 52-week low of Rs.19.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and broader market indices, reflecting persistent concerns over its financial metrics and market positioning.

Read full news article

View All News